{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T12:50:46Z","timestamp":1774875046976,"version":"3.50.1"},"reference-count":5,"publisher":"Oxford University Press (OUP)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Age Ageing"],"DOI":"10.1093\/ageing\/afw253","type":"journal-article","created":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T15:19:37Z","timestamp":1482419977000},"source":"Crossref","is-referenced-by-count":4,"title":["Pisa syndrome due to donepezil: pharmacokinetic interactions to blame?"],"prefix":"10.1093","author":[{"given":"David","family":"Pollock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette","family":"McGuinness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony Peter","family":"Passmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,1,18]]},"reference":[{"key":"2017012417100675000_afw253v2.1","first-page":"272","article-title":"Cholinesterase inhibitors and Pisa syndrome: a pharmacovigilance study","volume":"34","author":"Zannas","year":"2014","journal-title":"Pharmacology"},{"key":"2017012417100675000_afw253v2.2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200216030-00003"},{"key":"2017012417100675000_afw253v2.3","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S1474-4422(16)30173-9","article-title":"Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment","volume":"15","author":"Barone","year":"2016","journal-title":"Lancet Neurol."},{"key":"2017012417100675000_afw253v2.4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00228-016-2033-1","article-title":"Donepezil plasma concentrations, CYP2D6 and CYP3A4 phenotypes, and cognitive outcome in Alzheimer's disease","volume":"72","author":"Coin","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"2017012417100675000_afw253v2.5","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-014-0144-0"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ageing\/article-pdf\/46\/3\/529\/13897585\/afw253.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T14:44:01Z","timestamp":1503585841000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article-lookup\/doi\/10.1093\/ageing\/afw253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,18]]},"references-count":5,"alternative-id":["10.1093\/ageing\/afw253"],"URL":"https:\/\/doi.org\/10.1093\/ageing\/afw253","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,18]]}}}